These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37111679)

  • 41. Temporomandibular disorders, head and orofacial pain: cervical spine considerations.
    Kraus S
    Dent Clin North Am; 2007 Jan; 51(1):161-93, vii. PubMed ID: 17185065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (-)-α-Bisabolol reduces orofacial nociceptive behavior in rodents.
    Melo LT; Duailibe MA; Pessoa LM; da Costa FN; Vieira-Neto AE; de Vasconcellos Abdon AP; Campos AR
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):187-195. PubMed ID: 27900410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Temporomandibular joint steroid injections in patients with juvenile idiopathic arthritis: an observational pilot study on the long-term effect on signs and symptoms.
    Stoustrup P; Kristensen KD; Küseler A; Pedersen TK; Herlin T
    Pediatr Rheumatol Online J; 2015 Dec; 13():62. PubMed ID: 26689191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats.
    Seol TK; Lee W; Park S; Kim KN; Kim TY; Oh YN; Jun JH
    Korean J Anesthesiol; 2017 Oct; 70(5):561-566. PubMed ID: 29046777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuropathic orofacial pain: Characterization of different patient groups using the ICOP first edition, in a tertiary level Orofacial Pain Clinic.
    Handa S; Keith DA; Abou-Ezzi J; Rosèn A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Dec; 132(6):653-661. PubMed ID: 34518134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma IL-8 signature correlates with pain and depressive symptomatology in patients with burning mouth syndrome: Results from a pilot study.
    Barry A; O'Halloran KD; McKenna JP; McCreary C; Downer EJ
    J Oral Pathol Med; 2018 Feb; 47(2):158-165. PubMed ID: 29194773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-occurrence of Pain Symptoms and Somatosensory Sensitivity in Burning Mouth Syndrome: A Systematic Review.
    Moisset X; Calbacho V; Torres P; Gremeau-Richard C; Dallel R
    PLoS One; 2016; 11(9):e0163449. PubMed ID: 27657531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of ultra-micronized palmitoylethanolamide (um-PEA) in geriatric patients with chronic pain: study protocol for a series of N-of-1 randomized trials.
    Marcucci M; Germini F; Coerezza A; Andreinetti L; Bellintani L; Nobili A; Rossi PD; Mari D
    Trials; 2016 Jul; 17():369. PubMed ID: 27473188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence.
    Scuteri D; Guida F; Boccella S; Palazzo E; Maione S; Rodríguez-Landa JF; Martínez-Mota L; Tonin P; Bagetta G; Corasaniti MT
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pain Part 5a: Chronic (Neuropathic) Orofacial Pain.
    Renton T; Kahwaja N
    Dent Update; 2015 Oct; 42(8):744-6, 749-50, 753-4 passim. PubMed ID: 26685473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR-α agonist and effective nutraceutical.
    Hesselink JM
    J Pain Res; 2013; 6():625-34. PubMed ID: 23964161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a Rat Model of Mechanically Induced Tunable Pain and Associated Temporomandibular Joint Responses.
    Kartha S; Zhou T; Granquist EJ; Winkelstein BA
    J Oral Maxillofac Surg; 2016 Jan; 74(1):54.e1-10. PubMed ID: 26433038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients.
    Noce A; Albanese M; Marrone G; Di Lauro M; Pietroboni Zaitseva A; Palazzetti D; Guerriero C; Paolino A; Pizzenti G; Di Daniele F; Romani A; D'Agostini C; Magrini A; Mercuri NB; Di Daniele N
    Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33917573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Xerostomia and salivary flow in patients with orofacial pain compared with controls.
    da Silva LA; Teixeira MJ; de Siqueira JT; de Siqueira SR
    Arch Oral Biol; 2011 Oct; 56(10):1142-7. PubMed ID: 21612767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Photobiomodulation therapy on the palliative care of temporomandibular disorder and orofacial/cervical skull pain: study protocol for a randomized controlled clinical trial.
    Carvalho FR; Barros RQ; Gonçalves AS; Freitas PM
    Trials; 2019 Apr; 20(1):200. PubMed ID: 30954086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals.
    Re G; Barbero R; Miolo A; Di Marzo V
    Vet J; 2007 Jan; 173(1):21-30. PubMed ID: 16324856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
    Burgos E; Pascual D; Martín MI; Goicoechea C
    Eur J Pain; 2010 Jan; 14(1):40-8. PubMed ID: 19318283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COX-2 selective inhibitors: a literature review of analgesic efficacy and safety in oral-maxillofacial surgery.
    Cicconetti A; Bartoli A; Ripari F; Ripari A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Feb; 97(2):139-46. PubMed ID: 14970772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
    Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
    Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A 10-year overview of chronic orofacial pain in patients at an oral medicine center in Iran.
    Taheri JB; Anbari F; Sani SK; Mirmoezi SM; Khalighi HR
    J Dent Anesth Pain Med; 2022 Aug; 22(4):289-294. PubMed ID: 35991358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.